| scholarly article | Q13442814 |
| P50 | author | Markus Büchler | Q89169 |
| Helmut Friess | Q15453363 | ||
| P2093 | author name string | Yokoyama M | |
| Korc M | |||
| Ebert M | |||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5775-5778 | |
| P577 | publication date | 1994-11-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer | |
| P478 | volume | 54 |
| Q36572989 | A Novel Transcriptional Regulatory Region within the Core Promoter of the Hepatocyte Growth Factor Gene Is Responsible for Its Inducibility by Cytokines via the C/EBP Family of Transcription Factors |
| Q42017784 | A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma |
| Q33434042 | A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer |
| Q44510418 | Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin |
| Q35753150 | Activation of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System and Redistribution of E-Cadherin Are Associated with Hepatocyte Growth Factor-Induced Motility of Pancreas Tumor Cells Overexpressing Met |
| Q41451381 | Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers |
| Q41205527 | Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells |
| Q33899938 | Biological approaches to therapy of pancreatic cancer |
| Q34082960 | Chemoprevention strategies for pancreatic cancer |
| Q74433027 | Co-expression of hepatocyte growth factor and its receptor in human prostate cancer |
| Q35753107 | Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma |
| Q34619273 | Crizotinib exhibits antitumor activity by targeting ALK signaling not c-MET in pancreatic cancer |
| Q36116282 | Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma |
| Q41080997 | Establishment and immunocharacterization of an immortalized pancreatic cell line derived from the H-2Kb-tsA58 transgenic mouse |
| Q73003047 | Evaluation of the tyrosine kinase domain of the Met proto-oncogene in sporadic ovarian carcinomas* |
| Q54645357 | Expression and Prognostic Significance of CD151, c-Met, and Integrin alpha3/alpha6 in Pancreatic Ductal Adenocarcinoma |
| Q55284672 | Expression of c-met/HGF receptor in human non-small cell lung carcinomas in vitro and in vivo and its prognostic significance. |
| Q37180159 | Gastrointestinal growth factors and hormones have divergent effects on Akt activation. |
| Q40708249 | Gene transduction of NK4, HGF antagonist, inhibits in vitro invasion and in vivo growth of human pancreatic cancer. |
| Q40939409 | Growth factor regulation of integrin-mediated cell motility |
| Q36236835 | Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. |
| Q35798481 | Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis |
| Q35796063 | Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma |
| Q36547939 | Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer |
| Q41188806 | Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis |
| Q33863966 | Hepatocyte growth factor/scatter factor-induced intracellular signalling |
| Q54976417 | Imaging c-Met expression using 18F-labeled binding peptide in human cancer xenografts. |
| Q30481528 | Immunohistochemical analysis of changes in signaling pathway activation downstream of growth factor receptors in pancreatic duct cell carcinogenesis |
| Q34745711 | Immunohistochemical demonstration of MET overexpression in human intrahepatic cholangiocarcinoma and in hepatolithiasis |
| Q79269259 | Impact of c-Met expression on angiogenesis in soft tissue sarcomas: correlation to microvessel-density |
| Q53461580 | Inhibition of cancer cell motility and invasion by interleukin-12. |
| Q37356529 | Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model |
| Q41977380 | Intermediate Cells in Human Prostate Epithelium Are Enriched in Proliferative Inflammatory Atrophy |
| Q58738114 | Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer |
| Q35691904 | Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors |
| Q74454051 | Localization of Hepatocyte Growth Factor and Its Receptor met in Endocrine Cells and Related Tumors of the Gut and Pancreas: An Immunohistochemical Study |
| Q35399426 | Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components |
| Q27334957 | Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer |
| Q35085975 | Molecular biology of pancreatic cancer |
| Q36622822 | NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells |
| Q38939463 | Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction |
| Q55052293 | Overexpression of midkine in pancreatic duct adenocarcinomas induced by N-Nitrosobis(2-oxopropyl)amine in hamsters and their cell lines. |
| Q37448101 | PAX6 is expressed in pancreatic cancer and actively participates in cancer progression through activation of the MET tyrosine kinase receptor gene |
| Q92508947 | Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway |
| Q24800215 | Pathways for aberrant angiogenesis in pancreatic cancer |
| Q92364940 | Phage display screening of therapeutic peptide for cancer targeting and therapy |
| Q41152341 | Primary human fibroblasts induce diverse tumor invasiveness: involvement of HGF as an important paracrine factor |
| Q47305768 | Prognostic Value of c-MET Expression in Patients With Pancreatic Cancer Receiving Adjuvant and Neoadjuvant Chemoradiation Therapy. |
| Q41690572 | Role of Growth Factors in Pancreatic Cancer |
| Q37952015 | Role of MetMAb (OA-5D5) in c-MET active lung malignancies |
| Q30411399 | Simultaneous Profiling of 194 Distinct Receptor Transcripts in Human Cells |
| Q40855140 | The Use of Molecular Technology in the Differentiation of Pancreatic Cancer and Chronic Pancreatitis |
| Q41111881 | The cellular basis of metastasis |
| Q33886974 | c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer |
Search more.